The novel treatment of this peptide represents a exciting development in the care of the condition. Distinct from existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide819729.theblogfairy.com/40775387/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment